primary human coronary artery endothelial cells hcaecs (PromoCell)
Structured Review
Primary Human Coronary Artery Endothelial Cells Hcaecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 228 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronary+artery+endothelial+cells+hcaecs/Human+Coronary+Artery+Endothelial+Cells/pm42259138-95-0-11
Average 96 stars, based on 228 article reviews
Images
Related Articles
Cell Culture:Article Title: Initial contact guidance during cell spreading is contractility-independent. Article Snippet: .. 105 106 2.2 Cell culture 107 Human Article Title: Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties Article Snippet: .. Culture of human Article Title: Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties Article Snippet: .. Culture of human Article Title: Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells Article Snippet: Smooth muscle and endothelial cell culture: Mixed donor HUVECs were purchased from Promocell and cultured in endothelial cell growth medium (supplemented with 2% FCS, 0.4 % bovine hypothalamic extract, 0.1 ng/ml EGF, 1 ng/ml bFGF, 90 μg/ml heparin and 1 μg/ml hydrocortisone). .. Three different batches of human Article Title: Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr192 and compromises its cardioprotective activity Article Snippet: .. Cultures of human Wound Healing Assay:Article Title: Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr192 and compromises its cardioprotective activity Article Snippet: .. Cultures of human Isolation:Article Title: Cell-specific expression of uptake transporters--a potential approach for cardiovascular drug delivery devices. Article Snippet: Enhanced proliferation of human coronary artery smooth muscle cells (HCASMCs) and thereby formation of neointima is one of the factors contributing to failure of coronary stents.. Even if the use of drug eluting stents (DES) and thereby the local delivery of cytotoxic compounds has significantly improved the clinical outcome, unselective cytotoxic effects are assumed to hamper clinical success.. Novel pharmacological approaches are required to enhance cellular selectivity of locally delivered drugs. |
